Castle Biosciences Obtains $11,800,000 New Financing

Feed Type
Link
http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=60903b64-7760-4e33-b845-d251f3f05652
Date
8/14/2014
Company Name
Castle Biosciences
Mailing Address
2014 San Miguel Dr. Friendswood, TX 77546 USA
Company Description
Any time someone is diagnosed with cancer, many decisions have to be made regarding development of an optimal personalized treatment plan. Development of an optimal treatment plan requires accurate information regarding the diagnosis, prognosis and predicted responsiveness of a specific tumor – in other words accurate staging of the tumor.
Website
http://www.castlebiosciences.com
Transaction Type
Venture Equity
Transaction Amount
$11,800,000
Transaction Round
Undisclosed
Proceeds Purposes
The funds will be used to expand clinical availability of Castle Biosciences’ portfolio of practice-changing cancer diagnostic tests, including DecisionDx-Melanoma, its test to determine metastatic risk in patients with melanoma.
M&A Terms
Venture Investor
Venture Investor
Venture Investor